SkinHealth Systems annual return on equity
2021
2022
2023
2024
2025
SkinHealth Systems Return on Equity (ROE) Growth & History (SKIN)
SkinHealth Systems's return on equity was −16.87% for fiscal 2025.
View full SkinHealth Systems company overviewSkinHealth Systems annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −16.87% | +35.47 pp |
| 2024 | 2024-12-31 | −52.34% | +36.09 pp |
| 2023 | 2023-12-31 | −88.42% | −107.44 pp |
| 2022 | 2022-12-31 | 19.02% | +302.24 pp |
| 2021 | 2021-12-31 | −283.22% | — |
SkinHealth Systems quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −4.82% | −37.65 pp |
| Q1 2026 | 2026-03-31 | −11.40% | +9.23 pp |
| Q4 2025 | 2025-12-31 | −12.79% | +5.73 pp |
| Q3 2025 | 2025-09-30 | −15.80% | +12.58 pp |
| Q2 2025 | 2025-06-30 | 32.84% | +32.53 pp |
| Q1 2025 | 2025-03-31 | −20.63% | −19.53 pp |
| Q4 2024 | 2024-12-31 | −18.52% | −5.93 pp |
| Q3 2024 | 2024-09-30 | −28.38% | +30.26 pp |
| Q2 2024 | 2024-06-30 | 0.30% | −1.84 pp |
| Q1 2024 | 2024-03-31 | −1.11% | +11.58 pp |
| Q4 2023 | 2023-12-31 | −12.59% | −15.72 pp |
| Q3 2023 | 2023-09-30 | −58.63% | −58.61 pp |
| Q2 2023 | 2023-06-30 | 2.14% | +0.29 pp |
| Q1 2023 | 2023-03-31 | −12.68% | −22.60 pp |
| Q4 2022 | 2022-12-31 | 3.13% | +30.01 pp |
| Q3 2022 | 2022-09-30 | −0.03% | — |
| Q2 2022 | 2022-06-30 | 1.85% | — |
| Q1 2022 | 2022-03-31 | 9.92% | — |
| Q4 2021 | 2021-12-31 | −26.88% | — |
SkinHealth Systems return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, SkinHealth Systems's return on equity increased from −283.22% to −16.87%, a change of +266.35 percentage points. The latest reported quarter, Q2 2026, shows −4.82%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SkinHealth Systems source filings ↗